Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery

References

• NgamcherdtrakulWCastroDJGuSCurrent development of targeted oligonucleotide-based cancer therapies: perspective on HER2-positive breast cancer treatmentCancer Treat Rev201645192926930249
   PubMed Web of Science ®Google Scholar
• ChacónMMolpeceresJBergesLGuzmánMAberturasMRStability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriersEur J Pharm Sci1999829910710210732
   PubMed Web of Science ®Google Scholar
• FranksFFreeze-drying of bioproducts: putting principles into practiceEur J Pharm Biopharm19984532212299653626
   PubMed Web of Science ®Google Scholar
• AbdelwahedWDegobertGStainmesseSFessiHFreeze-drying of nanoparticles: formulation, process and storage considerationsAdv Drug Deliv Rev200658151688171317118485
   PubMed Web of Science ®Google Scholar
• NgamcherdtrakulWMorryJGuSCationic polymer modified mesoporous silica nanoparticles for targeted siRNA delivery to HER2+ breast cancerAdv Func Mater2015251826462659
   PubMed Web of Science ®Google Scholar
• GuSHuZNgamcherdtrakulWTherapeutic siRNA for drug-resistant HER2-positive breast cancerOncotarget2016712147271474126894975
   PubMedGoogle Scholar
• HolzerMVogelVManteleWSchwartzDHaaseWLangerKPhysicochemical characterisation of PLGA nanoparticles after freeze-drying and storageEur J Pharm Biopharm200972242843719462479
   PubMed Web of Science ®Google Scholar
• FontePAraujoFSeabraVReisSvan de WeertMSarmentoBCo-encapsulation of lyoprotectants improves the stability of protein-loaded PLGA nanoparticles upon lyophilizationInt J Pharm2015496285086226474964
   PubMedGoogle Scholar
• SaezAGuzmanMMolpeceresJAberturasMRFreeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugsEur J Pharm Biopharm200050337938711072195
   PubMed Web of Science ®Google Scholar
• BrusCKleemannEAignerACzubaykoFKisselTStabilization of oligonucleotide-polyethylenimine complexes by freeze-drying: physicochemical and biological characterizationJ Control Release200495111913115013239
   PubMed Web of Science ®Google Scholar
• YadavaPGibbsMCastroCHughesJAEffect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexesAAPS PharmSciTech20089233534118431646
   PubMed Web of Science ®Google Scholar
• MaitaniYAsoYYamadaAYoshiokaSEffect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiencyInt J Pharm20083561–2697518249511
   PubMed Web of Science ®Google Scholar
• KunduAKChandraPKHazariSStability of lyophilized siRNA nanosome formulationsInt J Pharm2012423252553422172291
   PubMed Web of Science ®Google Scholar
• BallRLBajajPWhiteheadKAAchieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilizationInt J Nanomedicine20171230531528115848
   PubMed Web of Science ®Google Scholar
• SametiMBohrGRavi KumarMNStabilisation by freeze-drying of cationically modified silica nanoparticles for gene deliveryInt J Pharm20032661–2516014559393
   PubMed Web of Science ®Google Scholar
• AlkilanyAMAbulateefehSRMillsKKColloidal stability of citrate and mercaptoacetic acid capped gold nanoparticles upon lyophilization: effect of capping ligand attachment and type of cryoprotectantsLangmuir20143046137991380825356538
   PubMed Web of Science ®Google Scholar
• ClelandJLLamXKendrickBA specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibodyJ Pharm Sci200190331032111170024
   PubMed Web of Science ®Google Scholar
• BuchmanYKLelloucheEZigdonSBechorMMichaeliSLelloucheJPSilica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applicationsBioconjug Chem201324122076208724180511
   PubMed Web of Science ®Google Scholar
• du ManoirJMFranciaGManSStrategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer XenograftsClin Cancer Res200612390491616467105
   PubMed Web of Science ®Google Scholar
• KolhePAmendESinghSKImpact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregationBiotechnol Prog201026372773320039442
   PubMed Web of Science ®Google Scholar
• Pikal-ClelandKACarpenterJFLyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidaseJ Pharm Sci20019091255126811745778
   PubMed Web of Science ®Google Scholar
• CroyleMAChengXWilsonJMDevelopment of formulations that enhance physical stability of viral vectors for gene therapyGene Ther20018171281129011571564
   PubMed Web of Science ®Google Scholar
• Pikal-ClelandKARodriguez-HornedoNAmidonGLCarpenterJFProtein denaturation during freezing and thawing in phosphate buffer systems: monomeric and tetrameric beta-galactosidaseArch Biochem Biophys2000384239840611368330
   PubMed Web of Science ®Google Scholar
• CarpenterJFPikalMJChangBSRandolphTWRational design of stable lyophilized protein formulations: some practical advicePharm Res19971489699759279875
   PubMed Web of Science ®Google Scholar
• AbdelwahedWDegobertGFessiHA pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimizationInt J Pharm20063091–217818816326053
   PubMed Web of Science ®Google Scholar
• KimuraYSumiyoshiMHigh-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing miceNutr Cancer200759220721618001216
   PubMed Web of Science ®Google Scholar
• YangGGilstrapKZhangAXuLXHeXCollapse temperature of solutions important for lyopreservation of living cells at ambient temperatureBiotechnol Bioeng2010106224725920148402
   PubMed Web of Science ®Google Scholar
• PatelSMDoenTPikalMJDetermination of end point of primary drying in freeze-drying process controlAAPS PharmSciTech2010111738420058107
   PubMed Web of Science ®Google Scholar